AKT1 and ovarian carcinoma: In summary, we have identified a metabolic vulnerability in the majority of ovarian cancer cells during mitotic arrest arising from a striking decrease in AKT activity, a reduction in glucose 6-phosphate, and a significant decrease in ATP levels.